Skip to main content

Scientists discover 'switch' that helps breast cancer spread around the body

The early-stage research, led by scientists from Imperial College London and The Institute of Cancer Research, London, identified a genetic 'switch' in breast cancer cells that boosts the production of a type of internal scaffolding.
This scaffolding is a type of protein, called Keratin-80, and related to the protein that helps keep hair strong. Boosting the amount of this scaffolding makes the cancer cells more rigid, which the researchers say may help the cells clump together and travel in the blood stream to other parts of the body.
The researchers, who published their work in the journal Nature Communications, studied human breast cancer cells treated with a common type of breast cancer drug called aromatase inhibitors.
The team found the same switch is involved in breast cancer cells becoming resistant to the medication (meaning the drugs are no longer effective if the cancer returns).
Targeting this switch with a different drug could help reverse this resistance, and make the cancer less likely to spread, explained Dr Luca Magnani, lead author of the research from the Department of Surgery and Cancer at Imperial: "Breast cancer is the most common cancer in the U.K., and causes 55,200 new cases every year. Aromatase inhibitors are effective at killing cancer cells, but within a decade post-surgery around 30 per cent of patients will relapse and see their cancer return -- usually because the cancer cells have adapted to the drug. Even worse, when the cancer comes back it has usually spread around the body -- which is difficult to treat."
Dr Magnani said: "Up until now we didn't know the reasons behind this, but our early-stage study suggests a type of genetic switch -- called a transcription factor -- can turn on genes that cause the cancer cells to not only become resistant to the treatment, but move into health tissue around the body. This research now needs to be followed up with larger studies, but if confirmed, targeting this genetic switch could prevent cancer cells from becoming resistant to the drugs, and from spreading to other areas of the body."
Aromatase inhibitors are used to treat a type of breast cancer called oestrogen-receptor positive. These make up over 70 per cent of all breast cancers, and are fueled by the hormone oestrogen.
These cancers are usually treated with surgery to remove the tumour, followed by a course of targeted hormone therapy -- usually either aromatase inhibitors or the drug tamoxifen, which blocks oestrogen receptors.
Aromatase inhibitors are usually given to post-menopausal women, and prevent oestrogen from being produced in other tissues. Although the women's ovaries have stopped producing oestrogen, some of the hormone is still made in several other tissues by an enzyme called aromatase. The medication prevents this enzyme making oestrogen.
However, around 30 per cent of breast cancer patients taking aromatase inhibitors see their cancer eventually return. This returning cancer is usually metastatic, meaning it has spread around the body, and the tumours are often now resistant to aromatase inhibitors.
In previous research, the same group discovered that cancer cells become resistant to aromatase inhibitors by making an alternative source of 'fuel'. The team discovered that when aromatase inhibitors starve cancer cells of oestrogen, some cells adapt by increasing production of cholesterol, which they then use for energy to survive. This means that if the cancer returns, it can no longer be killed by the same type of drugs.
In the latest research, which used human breast cancer cell cultures in the laboratory, the research team found the switch that turns on genes that increase cholesterol production also activates genes that make the cells more rigid and prone to invade nearby tissues.
The team also found that in women whose cancers had spread around the body, the cells contained higher amounts of Keratin-80.
The team say larger scale patient studies are now needed to confirm the findings, but the research could provide new avenues for helping treat breast cancer that returns and spreads around the body.
Dr Magnani explained: "Although the spread of cancer around the body affects many patients, scientists are still unsure about the molecular processes that drive the movement of cells. This research sheds light on this process, and also suggests it is controlled by the same switch as drug resistance. These findings need to be replicated in bigger trials, but could potential provide a way of stopping both drug resistance and cancer spread."
Dr Fernando Calvo, who carried out the research as Team Leader in Tumour Microenvironment at The Institute of Cancer Research (ICR), said:
"Tumour evolution is one of the biggest challenges facing cancer researchers. By working out how tumours evolve drug resistance, we can find new ways to treat the cancer effectively, or even prevent resistance developing in the first place.
"Our study shows how drug resistance and the invasiveness of cancer cells are interconnected in breast cancer through changes in cell shape. If we understand how to block resistance, we might also be able to prevent the cancer spreading throughout the body -- which would be an important step in treating breast cancer more effectively."
Story Source:
Materials provided by Imperial College London. Original written by Kate Wighton. 
Note: Content may be edited

Comments

Post a Comment

Popular posts from this blog

Dark matter may be older than the Big Bang

Dark matter, which researchers believe make up about 80% of the universe's mass, is one of the most elusive mysteries in modern physics. What exactly it is and how it came to be is a mystery, but a new Johns Hopkins University study now suggests that dark matter may have existed before the Big Bang. The study, published August 7 in  Physical Review Letters , presents a new idea of how dark matter was born and how to identify it with astronomical observations. "The study revealed a new connection between particle physics and astronomy. If dark matter consists of new particles that were born before the Big Bang, they affect the way galaxies are distributed in the sky in a unique way. This connection may be used to reveal their identity and make conclusions about the times before the Big Bang too," says Tommi Tenkanen, a postdoctoral fellow in Physics and Astronomy at the Johns Hopkins University and the study's author. While not much is known about its origins,...
Post a Comment
Read more

All of the starlight ever produced by the observable universe measured

All of the starlight ever produced by the observable universe measured The team's measurement, collected from Fermi data, has never been done before. This map of the entire sky shows the location of 739 blazars used in the Fermi Gamma-ray Space Telescope’s measurement of the extragalactic background light (EBL). The background shows the sky as it appears in gamma rays with energies above 10 billion electron volts, constructed from nine years of observations by Fermi’s Large Area Telescope. The plane of our Milky Way galaxy runs along the middle of the plot. From their laboratories on a rocky planet dwarfed by the vastness of space, Clemson University scientists have managed to measure all of the starlight ever produced throughout the history of the observable universe. Astrophysicists believe that our universe, which is about 13.7 billion years old, began forming the first stars when it was a few hundred million years old. Since then, the universe has become a st...
Post a Comment
Read more

Reflecting antiferromagnetic arrangements

Reflecting antiferromagnetic arrangements : Brookhaven Lab physicists Claudio Mazzoli (left) and Mark Dean at the Coherent Soft X-ray Scattering (CSX) beamline at the National Synchrotron Light Source II. Mazzoli and Dean are part of the team of scientists led by Rutgers University that used the CSX beamline to image some magnetic domains in an iron-based 'antiferromagnetic' material. The ability to image these domains is key to developing spintronics, or spin electronics, for practical applications. A team led by Rutgers University and including scientists from the U.S. Department of Energy's (DOE) Brookhaven National Laboratory has demonstrated an x-ray imaging technique that could enable the development of smaller, faster, and more robust electronics. Described in a paper published on Nov. 27 in  Nature Communications , the technique addresses a primary limitation in the emerging research field of "spintronics," or spin electronics, using magneti...
Post a Comment
Read more